cyclosporine and Severe Acute Respiratory Syndrome

cyclosporine has been researched along with Severe Acute Respiratory Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Fischereder, M; Guba, MO; Kemmner, S; Schönermarck, U; Stangl, M1
Beugeling, C; de Wilde, AH; Falzarano, D; Feldmann, H; Fett, C; Martellaro, C; Perlman, S; Posthuma, CC; Snijder, EJ; Zevenhoven-Dobbe, JC1
Carbajo-Lozoya, J; Ditt, V; Drosten, C; Friedel, CC; Haas, J; Herrler, G; Herzog, P; Hilgenfeld, R; Kallies, S; Kögl, M; Kuri, T; Müller, MA; Niemeyer, D; Pfefferle, S; Pöhlmann, S; Pumpor, K; Schöpf, J; Schwarz, F; Schwegmann-Wessels, C; Steffen, I; Stellberger, T; Thiel, HJ; Thiel, V; von Brunn, A; von Dall'Armi, E; Weber, F; Zimmer, R; Züst, R1

Other Studies

3 other study(ies) available for cyclosporine and Severe Acute Respiratory Syndrome

ArticleYear
Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
    Kidney international, 2020, Volume: 98, Issue:2

    Topics: Betacoronavirus; Calcineurin; Calcineurin Inhibitors; Coronavirus Infections; COVID-19; Cyclosporine; Humans; Kidney Transplantation; Pandemics; Pneumonia; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome

2020
Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model.
    Virus research, 2017, 01-15, Volume: 228

    Topics: Animals; Antiviral Agents; Cell Line; Cells, Cultured; Coronavirus Infections; Cyclosporine; Cytopathogenic Effect, Viral; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Mice; Middle East Respiratory Syndrome Coronavirus; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Virus Replication

2017
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.
    PLoS pathogens, 2011, Volume: 7, Issue:10

    Topics: Animals; Antiviral Agents; Caco-2 Cells; Chlorocebus aethiops; Cyclophilins; Cyclosporine; HEK293 Cells; Host-Pathogen Interactions; Humans; Jurkat Cells; Protease Inhibitors; Protein Interaction Mapping; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Two-Hybrid System Techniques; Vero Cells; Viral Proteins; Virus Replication

2011